HeartWare Presents New VAD Data; Thrombus Rates Prompt Concerns

HeartWare presented longer-term data from its bridge-to-transplant ADVANCE trial for its left ventricular assist device earlier this month. The data largely mirrored results presented last year, but newly increased thrombus rates prompted questions.